Showing results (1-10 of 375) with videos related to
Sort By:
Pageof 38
International Journal of Clinical Practice. Supplement|April 1, 2003
Buprenorphine: new pharmacological aspectsAlan CowanInternational Journal of Clinical Practice. Supplement|April 3, 2003
The clinical tolerability profile of alendronateN Watts, D Freedholm, A DaifotisInternational Journal of Clinical Practice. Supplement|July 26, 2002
The tolerability and safety of cholinesterase inhibitors in the treatment of dementiaF InglisInternational Journal of Clinical Practice. Supplement|November 22, 2001
Pharmacoeconomic impact of HOPEJ B Ostergren, I Björholt, F Andersson, et al.International Journal of Clinical Practice. Supplement|November 22, 2001
Vascular protection: current possibilities and future perspectivesT F LüscherInternational Journal of Clinical Practice. Supplement|November 22, 2001
Diabetes and the HOPE study: implications for macrovascular and microvascular diseaseH C GersteinInternational Journal of Clinical Practice. Supplement|February 5, 2003
Disease-modifying therapy in relapsing--remitting multiple sclerosis: efficacy is paramountE CristianoInternational Journal of Clinical Practice. Supplement|February 5, 2003
Once weekly interferon beta for multiple sclerosis is superseded by higher and more frequent dosingL D BlumhardtInternational Journal of Clinical Practice. Supplement|August 9, 2002
Abnormalities of the electrocardiogram during hypoglycaemia: the cause of the dead in bed syndrome?Simon R HellerInternational Journal of Clinical Practice. Supplement|August 9, 2002
Can reducing peaks prevent type 2 diabetes: implication from recent diabetes prevention trialsSteven M HaffnerPageof 38